Andrew J. D'Silva Optimize Rx Corp (OPRX) insider trading activity

Andrew J. D'Silva is Chief Business Officer of OptimizeRx Corp. Currently has a direct ownership of 44,735 shares of OPRX, which is worth approximately $679,077. The most recent transaction as insider was on Dec 19, 2025, when has been sold 703 shares (Common Stock) at a price of $13.51 per share, resulting in proceeds of $9,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.7K

3.39% 3M change

n/a 12M change

Total Value Held $679,077

Andrew J. D'Silva Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2025	SELL Payment of exercise price or tax liability	$9,497 $13.51 p/Share	703 Reduced 1.55%	44,735 Common Stock
Dec 11 2025	SELL Payment of exercise price or tax liability	$12,178 $14.03 p/Share	868 Reduced 1.87%	45,438 Common Stock
Oct 03 2025	SELL Payment of exercise price or tax liability	$14,887 $18.75 p/Share	794 Reduced 1.69%	46,306 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$7,857 $18.98 p/Share	414 Reduced 0.87%	47,100 Common Stock
Aug 21 2025	BUY Grant, award, or other acquisition	-	10,417 Added 17.98%	47,514 Common Stock

AJD

Andrew J. D'Silva

Chief Business Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX

Account